期刊
OPTICA
卷 9, 期 5, 页码 532-544出版社
Optica Publishing Group
DOI: 10.1364/OPTICA.454790
关键词
-
类别
资金
- U.S. Department of Energy [DE-SC0020338]
- National Institutes of Health [R01CA207725, R01CA237267, R01CA250636]
- UCLA Jonsson Comprehensive Cancer Center Seed Grant Program
- Swiss National Science Foundation
- U.S. Department of Energy (DOE) [DE-SC0020338] Funding Source: U.S. Department of Energy (DOE)
SwissSPAD2, a large time-gated single-photon avalanche diode (SPAD) camera, has been demonstrated to be suitable for in vivo near-infrared fluorescence lifetime imaging (FLI) measurements. It shows excellent performance in well-controlled in vitro experiments and has been successfully applied to in vivo studies of target-drug engagement in deep tissues.
Near-infrared (NIR) fluorescence lifetime imaging (FLI) provides a unique contrast mechanism to monitor biological parameters and molecular events in vivo. Single-photon avalanche diode (SPAD) cameras have been recently demonstrated in FLI microscopy (FLIM) applications, but their suitability for in vivo macroscopic FLI (MFLI) in deep tissues remains to be demonstrated. Herein, we report in vivo NIR MFLI measurement with SwissSPAD2, a large time-gated SPAD camera. We first benchmark its performance in well-controlled in vitro experiments, ranging from monitoring environmental effects on fluorescence lifetime, to quantifying Forster resonant energy transfer (FRET) between dyes. Next, we use it for in vivo studies of target-drug engagement in live and intact tumor xenografts using FRET. Information obtained with SwissSPAD2 was successfully compared to that obtained with a gated intensified charge-coupled device (ICCD) camera, using two different approaches. Our results demonstrate that SPAD cameras offer a powerful technology for in vivo preclinical applications in the NIR window. (C) 2022 Optica Publishing Group under the terms of the Optica Open Access Publishing Agreement
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据